Committee for Proprietary Medicinal Products (cpmp) Note for Guidance on Clinical Investigation of Medicinal Products in the Treatment of Hypertension
ثبت نشده
چکیده
منابع مشابه
The European Agency for the Evaluation of Medicinal Products Evaluation of Medicines for Human Use
In the early 1990’s, occasional incidents of transmission of enveloped viruses (hepatitis B (HBV) and C viruses (HCV)) and other blood-borne viruses, including hepatitis A virus (HAV) occurred with plasma-derived medicinal products. As a result, the effectiveness of processes for inactivation/ removal of enveloped viruses was increased. In addition, the Committee on Proprietary Medicinal Produc...
متن کاملGuideline on clinical investigation of medicinal products in the treatment of lipid disorders
This guideline replaces the ‘Note for guidance on clinical investigation of medicinal products in the treatment of lipid disorders (CPMP/EWP/3020/03)’. Rev. 1 and Rev. 2 were combined: Rev. 1 was regarding imaging surrogate endpoints Rev. 2 was regarding the need for outcome studies based on safety data at the time of Marketing Authorisation Application.
متن کاملCPMP note for guidance: clinical trials on the medicinal products in the treatment of cardiac failure.
Additional Notes This note for guidance is intended to provide guidance for the clinical investigation of medicinal products in the treatment of cardiac failure. It should be read in conjunction with Part 4 of the Annex of Directive 75/318/EEC as amended, and all other relevant guidelines as applicable and is intended to assist in the application of the Directive. This version replaces the prev...
متن کاملDraft Guideline on clinical investigation of medicinal products for the treatment of acute heart failure (CHMP/EWP/2986/03 Rev 1)
7 This guideline replaces addendum CPMP/EWP/2986/03 " Note for guidance on clinical investigation of 8 medicinal products for the treatment of cardiac failure – addendum on acute cardiac failure ". 9 10 Comments should be provided using this template. The completed comments form should be sent to [email protected] 11 Keywords Acute heart failure, acute decompensated heart failure, ...
متن کاملDraft Guideline on Clinical Investigation of Medicial Products in the Treatment of Diabetes Mellitus
Discussion in the Efficacy Working Party June 2000 – May 2001 Transmission to CPMP July 2001 Release for consultation July 2001 Deadline for comments January 2002 Discussion in the Efficacy Working Party April 2002 Transmission to CPMP May 2002 Adoption by CPMP May 2002 Date for coming into operation November 2002 Draft Rev. 1 agreed by Efficacy Working Party January 2010 Adoption by CHMP for r...
متن کامل